Quick Answer
Autonomix Medical, Inc. reported Net Income Loss of -$11.41 million for the year ending 2025.
- Autonomix Medical, Inc. showed an increase of +26.0% in Net Income Loss from 2024 to 2025.
- This data is from Autonomix Medical, Inc.'s annual report (Form 10-K), filed with the SEC on May 29, 2025.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: -$341.0 thousand | Q3 2022: -$448.0 thousand | Q4 2022: -$544.0 thousand | Q2 2023: -$865.0 thousand | Q3 2023: -$6.04 million | Q4 2023: -$3.11 million | Q1 2024: -$15.43 million | Q2 2024: -$2.70 million | Q3 2024: -$2.81 million | Q4 2024: -$2.71 million | Q1 2025: -$11.41 million | Q2 2025: -$3.34 million | Q3 2025: -$7.45 million | Q4 2025: -$3.26 million.
- Over the full 3 years of available data (2023 to 2025), Autonomix Medical, Inc.'s Net Income Loss has declined by 473.4%.
- Historical annual values: Fiscal year 2025: -$11.41 million | Fiscal year 2024: -$15.43 million | Fiscal year 2023: -$1.99 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: